Suppr超能文献

用于鼻腔给药的富含鼠尾草酸的热敏脂质纳米凝胶的设计与评价:体外渗透、鼻纤毛毒性及抗氧化评估

Design and evaluation of carnosic acid-loaded thermosensitive lipidic nanogels for nasal delivery: ex vivo permeation, nasal ciliotoxicity, and antioxidant assessment.

作者信息

Warsi Musarrat Husain, Ali Abuzer, Mirza Mohd Aamir, Zafar Ameeduzzafar, Mujtaba Md Ali

机构信息

Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, 21944 Saudi Arabia.

Department of Pharmacognosy, College of Pharmacy, Taif University, Taif, 21944 Saudi Arabia.

出版信息

3 Biotech. 2025 Jun;15(6):193. doi: 10.1007/s13205-025-04367-6. Epub 2025 May 28.

Abstract

Carnosic acid (CA) is a diterpene phenolic compound derived from the leaves of , known for its neuroprotective, anti-inflammatory, and antioxidant properties. However, its effectiveness is limited due to poor solubility and a low dissolution rate. To enhance its neuroprotective potential, a thermosensitive intranasal nanogel incorporated with CA-loaded nanostructured lipid carriers (NLC) was developed using a quality-by-design approach to improve delivery and efficacy of CA. NLC were developed by melt emulsification followed by ultrasonication method by employing solid lipid (Precirol® ATO 5), liquid lipid (Capryol 90), and surfactant (Tween 60). The developed NLC was optimized using a central composite design and exhibited a mean particle size of 114.3 ± 2.62 nm, a polydispersity index of 0.285 ± 0.032, and an entrapment efficiency of 75.25 ± 0.71%. Further, thermosensitive in situ gel was developed and optimized for its gelling strength, gelation temperature, texture profile. The developed gel containing the optimized NLC was assessed for in vitro release and ex vivo permeability using goat nasal mucosa followed by antioxidant study. The nasal ciliotoxicity of developed nanogel was reviewed by histopathological study. The nanogel demonstrated a favorable texture profile and gelling strength, with a gelation temperature of 29.63 ± 0.15 °C. In vitro release studies indicated a sustained release of CA, with 52.96 ± 1.69% released over 12 h, and a 2.76-fold increase in nasal permeation compared to the control gel. Antioxidant assays showed that the optimized CA-NLC gel possessed strong free radical scavenging activity, comparable to that of the standard antioxidant, butylated hydroxyanisole. Finally, developed nanogel exhibited safe profile for intranasal delivery as revealed by histopathological study. All these findings confirm the capability of developed thermosensitive in situ nanogel for intranasal delivery.

摘要

迷迭香酸(CA)是一种源自迷迭香叶的二萜酚类化合物,以其神经保护、抗炎和抗氧化特性而闻名。然而,由于其溶解度差和溶解速率低,其有效性受到限制。为了增强其神经保护潜力,采用质量源于设计的方法开发了一种含有载有CA的纳米结构脂质载体(NLC)的热敏鼻内纳米凝胶,以改善CA的递送和疗效。通过熔融乳化法,随后采用固体脂质(Precirol® ATO 5)、液体脂质(Capryol 90)和表面活性剂(吐温60)的超声法制备NLC。使用中心复合设计对所制备的NLC进行优化,其平均粒径为114.3±2.62nm,多分散指数为0.285±0.032,包封率为75.25±0.71%。此外,开发并优化了热敏原位凝胶的胶凝强度、凝胶化温度和质地剖面。使用山羊鼻黏膜对含有优化NLC的所开发凝胶进行体外释放和离体渗透性评估,随后进行抗氧化研究。通过组织病理学研究评估所开发纳米凝胶的鼻纤毛毒性。该纳米凝胶表现出良好的质地剖面和胶凝强度,凝胶化温度为29.63±0.15℃。体外释放研究表明CA持续释放,12小时内释放52.96±1.69%,与对照凝胶相比,鼻内渗透性增加2.76倍。抗氧化试验表明,优化后的CA-NLC凝胶具有较强的自由基清除活性,与标准抗氧化剂丁基羟基茴香醚相当。最后,组织病理学研究表明,所开发的纳米凝胶用于鼻内递送具有安全性。所有这些发现证实了所开发的热敏原位纳米凝胶用于鼻内递送的能力。

相似文献

2
Formulation and characterization of Mirtazapine loaded mucoadhesive cubosomal in-situ gel for intranasal delivery.
Ther Deliv. 2025 Jun;16(6):545-553. doi: 10.1080/20415990.2025.2479416. Epub 2025 Mar 16.
5
Difenoconazole-Loaded Nanostructured Lipid Carriers: Preparation, Characterization, and Evaluation.
Pharmaceuticals (Basel). 2025 May 23;18(6):780. doi: 10.3390/ph18060780.
6
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease.
Cochrane Database Syst Rev. 2025 Jan 7;1(1):CD013476. doi: 10.1002/14651858.CD013476.pub2.
7
Novel nanostructured lipid carriers with lurasidone hydrochloride for intranasal administration for improved bioavailability.
Ther Deliv. 2025 May;16(5):419-429. doi: 10.1080/20415990.2025.2477440. Epub 2025 Mar 24.

本文引用的文献

1
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport.
Pharmaceutics. 2024 Apr 1;16(4):481. doi: 10.3390/pharmaceutics16040481.
4
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.
J Nanobiotechnology. 2022 Aug 31;20(1):395. doi: 10.1186/s12951-022-01605-4.
8
Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin.
Int J Pharm. 2021 Nov 20;609:121131. doi: 10.1016/j.ijpharm.2021.121131. Epub 2021 Sep 24.
10
Non-Invasive Strategies for Nose-to-Brain Drug Delivery.
J Clin Trials. 2020;10(7). Epub 2020 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验